Amgen (AMGN) Q1 2012 Earnings Call April 24, 2012 5:00 pm ET Executives Arvind Sood - Vice President of Investor Relations Kevin W. Sharer - Chairman, Chief Executive Officer, Chairman of Executive Committee and Member of Equity Award Committee Robert A. Bradway - President, Chief Operating Officer and Director Jonathan M. Peacock - Chief Financial Officer and Executive Vice President Anthony C. Hooper - Executive Vice President of Global Commercial Operations Sean E. Harper - Executive Vice President of Research & Development Analysts Michael J. Yee - RBC Capital Markets, LLC, Research Division Matthew C. McAviney - Robert W. Baird & Co. Incorporated, Research Division Mark J. Schoenebaum - ISI Group Inc., Research Division Matthew Roden - UBS Investment Bank, Research Division Rachel L. McMinn - BofA Merrill Lynch, Research Division Eric Schmidt - Cowen and Company, LLC, Research Division Sapna Srivastava - Goldman Sachs Group Inc., Research Division Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division Yaron Werber - Citigroup Inc, Research Division Robyn Karnauskas - Deutsche Bank AG, Research Division Eun K. Yang - Jefferies & Company, Inc., Research Division Marshall Urist - Morgan Stanley, Research Division Ravi Mehrotra - Crédit Suisse AG, Research Division Charles Anthony Butler - Barclays Capital, Research Division Aleksandr Rabodzey John S. Sonnier - William Blair & Company L.L.C., Research Division PresentationOperator
My name is Marvin, and I will be your conference facilitator today for Amgen's First Quarter Earnings Conference Call. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin. Arvind Sood Thank you, Marvin, and good afternoon, everybody. I would like to welcome you to our first quarter conference call. We are off to a strong start in 2012, and we are looking forward to the many opportunities ahead. I'm joined today by several members of our leadership team, including Bob Bradway, our current President and CEO-elect; our Chief Financial Officer, John Peacock; Tony Hooper, our Head of Global Commercial Operations; and Sean Harper, our Head of R&D. This quarter represents milestones in many ways, with record performance for both revenues and adjusted earnings per share, and notably after 2 full decades, first as President and then as Chairman and CEO, Kevin Sharer will preside over his last call as our Chief Executive Officer. Kevin is with us this afternoon, but before I turn the call over to him, I will just provide our customary reminders.